Work

The sodium–glucose co‐transporter 2 inhibitor, empagliflozin, attenuates pulmonary vascular remodelling by inhibiting the phosphorylation of PDGF receptor‐β

Year: 2025

Type: article

Source: British Journal of Pharmacology

DOI: 10.1111/bph.70222

Authors: Ting‐ting Lyu, Jing‐yang Wang, Jiang‐Shan Tan, Tian‐qi Li, Yu‐yuan Shu, Yanmin Yang

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Fu Wai Hospital, State Key Laboratory of Cardiovascular Disease, Capital Medical University, Beijing Anzhen Hospital

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417178472

FWCI: 3.038

Cites: 53

Cited by: 5

Related to: